We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer.
- Authors
Treat, J A; Gonin, R; Socinski, M A; Edelman, M J; Catalano, R B; Marinucci, D M; Ansari, R; Gillenwater, H H; Rowland, K M; Comis, R L; Obasaju, C K; Belani, C P; Alpha Oncology Research Network
- Abstract
Paclitaxel-carboplatin is used as the standard regimen for patients with advanced or metastatic non-small-cell lung cancer (NSCLC). This trial was designed to compare gemcitabine + carboplatin or gemcitabine + paclitaxel to the standard regimen.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Vol 21, Issue 3, p540
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdp352